COVID-19

Regulating Through the COVID-19 Pandemic

How America Turns Competitors Into Colleagues

How America Turns Competitors Into Colleagues

The collaboration between pharmaceutical giants puts antitrust law at risk.

The Urgent Need for Indoor Air Quality Regulation

The Urgent Need for Indoor Air Quality Regulation

New scientific research and the COVID-19 pandemic should trigger a paradigm shift in indoor air quality regulation.

Accessibility Is Not Optional

Accessibility Is Not Optional

COVID-19 vaccine distribution campaigns must prioritize compliance with disability laws.

A Digital COVID-19 Vaccine Passport System Is Still Premature

A Digital COVID-19 Vaccine Passport System Is Still Premature

Questions of equity, access, and privacy demand answers before a vaccine passport will work.

Expanding Home Confinement During COVID-19

Expanding Home Confinement During COVID-19

A regulatory remedy can help reduce the federal prison population during the pandemic.

Religious Freedom or Pandemic Safety?

Religious Freedom or Pandemic Safety?

The Supreme Court blocked Governor Cuomo from enforcing COVID-19 restrictions on houses of worship.

Tackling Viral Variants

Tackling Viral Variants

FDA issues policy guidance to help medical product developers address COVID-19 viral variants.

The Tribal COVID-19 Response

The Tribal COVID-19 Response

Native communities have responded to the pandemic in fast-moving, expertise-driven, and innovative ways.

Vaccine Mandates in the Time of COVID-19

Vaccine Mandates in the Time of COVID-19

Experts examine the legality and efficacy of vaccine mandates.

The Justice Department Should Preserve Home Confinement

The Justice Department Should Preserve Home Confinement

The Biden Administration should reject arguments to re-incarcerate people released from prison during the COVID-19 pandemic.

Rallying Around Paid Family Leave

Rallying Around Paid Family Leave

Stakeholders weigh in on a potential federal paid-leave program.

Oh, When the Feds Go Marching-In

Oh, When the Feds Go Marching-In

Marching-in could allow federal government to commercialize inventions, but at the expense of patent rights.